1. Home
  2. EYEN vs VATE Comparison

EYEN vs VATE Comparison

Compare EYEN & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • VATE
  • Stock Information
  • Founded
  • EYEN 2014
  • VATE 1994
  • Country
  • EYEN United States
  • VATE United States
  • Employees
  • EYEN N/A
  • VATE N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • VATE Metal Fabrications
  • Sector
  • EYEN Health Care
  • VATE Industrials
  • Exchange
  • EYEN Nasdaq
  • VATE Nasdaq
  • Market Cap
  • EYEN 2.9M
  • VATE 98.2M
  • IPO Year
  • EYEN 2018
  • VATE 1996
  • Fundamental
  • Price
  • EYEN $10.56
  • VATE $5.25
  • Analyst Decision
  • EYEN Hold
  • VATE
  • Analyst Count
  • EYEN 4
  • VATE 0
  • Target Price
  • EYEN $2.00
  • VATE N/A
  • AVG Volume (30 Days)
  • EYEN 10.0M
  • VATE 19.8K
  • Earning Date
  • EYEN 08-11-2025
  • VATE 08-06-2025
  • Dividend Yield
  • EYEN N/A
  • VATE N/A
  • EPS Growth
  • EYEN N/A
  • VATE N/A
  • EPS
  • EYEN N/A
  • VATE N/A
  • Revenue
  • EYEN $67,063.00
  • VATE $1,066,100,000.00
  • Revenue This Year
  • EYEN $7,680.45
  • VATE N/A
  • Revenue Next Year
  • EYEN $315.38
  • VATE N/A
  • P/E Ratio
  • EYEN N/A
  • VATE N/A
  • Revenue Growth
  • EYEN 663.82
  • VATE N/A
  • 52 Week Low
  • EYEN $0.85
  • VATE $3.25
  • 52 Week High
  • EYEN $124.80
  • VATE $13.79
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 68.92
  • VATE 42.89
  • Support Level
  • EYEN $7.50
  • VATE $5.04
  • Resistance Level
  • EYEN $14.33
  • VATE $5.37
  • Average True Range (ATR)
  • EYEN 2.52
  • VATE 0.22
  • MACD
  • EYEN 0.60
  • VATE 0.02
  • Stochastic Oscillator
  • EYEN 69.15
  • VATE 33.87

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: